MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan · Delayed Price · Currency is TWD 4.420
-0.130 (-2.86%)
Aug 19, 2026, 10:19 AM CST
MARX Biotech Market Cap
MARX Biotech has a market cap or net worth of 2.38 billion as of August 18, 2026. Its market cap has increased by 5.24% in one year.
Market Cap
2.38B
Enterprise Value
2.52B
Revenue
584.74M
Ranking
n/a
PE Ratio
82.03
Stock Price
4.42
ChartMarket Cap Chart
Since February 5, 2024, MARX Biotech's market cap has decreased from 4.38B to 2.38B, a decrease of -45.81%. That is a compound annual growth rate of -21.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 2.38B | -2.62% |
| Dec 31, 2025 | 2.44B | -30.65% |
| Dec 31, 2024 | 3.52B | -19.77% |
| Feb 5, 2024 | 4.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 584.35B |
| Caliway Biopharmaceuticals | 159.43B |
| Lin BioScience | 78.44B |
| Pell Bio-Med Technology | 68.36B |
| A Plus Biotechnology | 2.53B |
| GlycoNex Incorporation | 2.53B |
| Wellell | 2.51B |
| Johnson Chemical Pharmaceutical Works | 2.48B |